首页 > 最新文献

Middle East Journal of Digestive Diseases最新文献

英文 中文
Small Bowel Lymphangiectasia Leading to Massive Gastrointestinal Bleeding: A Case Report. 小肠淋巴管扩张导致消化道大出血1例报告。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.34172/mejdd.2023.322
Farahnaz Safaei, Amir Sadeghi, Pardis Ketabi Moghadam, Peyman Taheri

Lymphangiomas are benign lymphatic system abnormalities that can appear anywhere on the skin and mucous membranes. Lymphangiomas are caused by congenital or acquired lymphatic system disorders. In the congenital form, although the cause is unknown it is said that it is formed by the incorrect attachment of lymphatic channels to the main lymphatic drainage duct before the age of 5 years. lymphangiectasia as a subgroup of lymphangioma occurs seldom in the small bowel, especially in adults. If that happens, protein-losing enteropathy will be the most common presenting sign. In the present study, we introduce a case of a 40-year-old man without a history of any congenital or acquired diseases who was admitted to the emergency room due to long-lasting obscure overt gastrointestinal (GI) bleeding. Normal upper and lower GI endoscopies were suggestive of GI bleeding originating from the small intestine. Despite receiving iron supplements, he continued to have melena and remained anemic. Further evaluation of the small intestine by deep enteroscopy revealed multiple white spots histologically consistent with dilated lymphatics. Intestinal lymphangiectasia was eventually introduced to be the final diagnosis of the patient.

淋巴管瘤是良性淋巴系统异常,可出现在皮肤和粘膜的任何地方。淋巴管瘤是由先天性或获得性淋巴系统疾病引起的。在先天性形式中,虽然病因不明,但据说是由于5岁以前淋巴通道与主要淋巴引流管的不正确连接而形成的。淋巴管扩张是淋巴管瘤的一个亚组,很少发生在小肠,尤其是在成人中。如果发生这种情况,蛋白质丢失性肠病将是最常见的表现。在本研究中,我们介绍一个没有任何先天性或获得性疾病史的40岁男性,因长期隐晦的显性胃肠道出血而被送入急诊室。正常上消化道和下消化道内窥镜检查提示消化道出血起源于小肠。尽管服用了补铁剂,他仍然患有黑黑症,并一直贫血。进一步的小肠深肠镜检查显示多个白色斑点,组织学上与扩张的淋巴管一致。肠淋巴管扩张最终被诊断为患者的最终诊断。
{"title":"Small Bowel Lymphangiectasia Leading to Massive Gastrointestinal Bleeding: A Case Report.","authors":"Farahnaz Safaei,&nbsp;Amir Sadeghi,&nbsp;Pardis Ketabi Moghadam,&nbsp;Peyman Taheri","doi":"10.34172/mejdd.2023.322","DOIUrl":"https://doi.org/10.34172/mejdd.2023.322","url":null,"abstract":"<p><p>Lymphangiomas are benign lymphatic system abnormalities that can appear anywhere on the skin and mucous membranes. Lymphangiomas are caused by congenital or acquired lymphatic system disorders. In the congenital form, although the cause is unknown it is said that it is formed by the incorrect attachment of lymphatic channels to the main lymphatic drainage duct before the age of 5 years. lymphangiectasia as a subgroup of lymphangioma occurs seldom in the small bowel, especially in adults. If that happens, protein-losing enteropathy will be the most common presenting sign. In the present study, we introduce a case of a 40-year-old man without a history of any congenital or acquired diseases who was admitted to the emergency room due to long-lasting obscure overt gastrointestinal (GI) bleeding. Normal upper and lower GI endoscopies were suggestive of GI bleeding originating from the small intestine. Despite receiving iron supplements, he continued to have melena and remained anemic. Further evaluation of the small intestine by deep enteroscopy revealed multiple white spots histologically consistent with dilated lymphatics. Intestinal lymphangiectasia was eventually introduced to be the final diagnosis of the patient.</p>","PeriodicalId":18517,"journal":{"name":"Middle East Journal of Digestive Diseases","volume":"15 1","pages":"60-62"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/71/82/mejdd-15-60.PMC10404075.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10324904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Accuracy of Vibration Controlled Transient Elastography as Non-invasive Assessment of Liver Fibrosis in Patients with Non-alcoholic Fatty Liver Disease. 振动控制瞬时弹性成像对非酒精性脂肪性肝病患者肝纤维化的诊断准确性
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.34172/mejdd.2023.316
Hossain Salehi, Amir Mohammad Salehi, Mohammad Ebrahim Ghamarchehreh, Elham Khanlarzadeh, Masoud Reza Sohrabi

Background: Liver biopsy remain as the gold standard for diagnosing hepatic fibrosis; however, it has some limitations, such as life-threatening complications, low acceptance by the patients, and variations in the related sample. Therefore, there is a need for the development of non-invasive investigations for diagnosing hepatic fibrosis. Vibration-controlled transient elastography (VCTE) is one of these non-invasive methods. Methods: This study included 73 patients suffering from non-alcoholic fatty liver disease (NAFLD) who were older than 18 years. The patients underwent VCTE at the Baqiatallah and Firoozgar hospitals. Then, they underwent a liver biopsy by an experienced radiologist in the same hospital. A receiver operating characteristic (ROC) curve of different fibrosis stages was used to evaluate the VCTE verification. Results: VCTE could detect any fibrosis levels (stage 1 and higher) with an area under the ROC curve (AUROC) of 0.381. Moreover, it detected stage 2-4 fibrosis with an AUROC of 0.400, stage 3-4 fibrosis with an AUROC of 0.687, and stage 4 fibrosis with an AUROC of 0.984. Conclusion: The VCTE has high clinical validity in diagnosing the advanced stages of fibrosis (stages 3, 4) and can be a suitable alternative to the invasive method of liver biopsy with high reliability.

背景:肝活检仍然是诊断肝纤维化的金标准;然而,它也有一些局限性,如危及生命的并发症,患者的接受度低,以及相关样本的差异。因此,有必要发展诊断肝纤维化的非侵入性检查。振动控制瞬态弹性成像(VCTE)就是其中一种非侵入性方法。方法:本研究纳入73例年龄大于18岁的非酒精性脂肪性肝病(NAFLD)患者。患者在Baqiatallah和Firoozgar医院接受了VCTE治疗。然后,他们在同一家医院接受了一位经验丰富的放射科医生的肝脏活检。采用不同纤维化分期的受试者工作特征(ROC)曲线评价VCTE的有效性。结果:VCTE可以检测到任何纤维化水平(1期及以上),ROC曲线下面积(AUROC)为0.381。此外,它检测到2-4期纤维化的AUROC为0.400,3-4期纤维化的AUROC为0.687,4期纤维化的AUROC为0.984。结论:VCTE诊断晚期肝纤维化(3、4期)具有较高的临床有效性,可作为有创肝活检的替代方法,可靠性高。
{"title":"Diagnostic Accuracy of Vibration Controlled Transient Elastography as Non-invasive Assessment of Liver Fibrosis in Patients with Non-alcoholic Fatty Liver Disease.","authors":"Hossain Salehi,&nbsp;Amir Mohammad Salehi,&nbsp;Mohammad Ebrahim Ghamarchehreh,&nbsp;Elham Khanlarzadeh,&nbsp;Masoud Reza Sohrabi","doi":"10.34172/mejdd.2023.316","DOIUrl":"https://doi.org/10.34172/mejdd.2023.316","url":null,"abstract":"<p><p><b>Background:</b> Liver biopsy remain as the gold standard for diagnosing hepatic fibrosis; however, it has some limitations, such as life-threatening complications, low acceptance by the patients, and variations in the related sample. Therefore, there is a need for the development of non-invasive investigations for diagnosing hepatic fibrosis. Vibration-controlled transient elastography (VCTE) is one of these non-invasive methods. <b>Methods:</b> This study included 73 patients suffering from non-alcoholic fatty liver disease (NAFLD) who were older than 18 years. The patients underwent VCTE at the Baqiatallah and Firoozgar hospitals. Then, they underwent a liver biopsy by an experienced radiologist in the same hospital. A receiver operating characteristic (ROC) curve of different fibrosis stages was used to evaluate the VCTE verification. <b>Results:</b> VCTE could detect any fibrosis levels (stage 1 and higher) with an area under the ROC curve (AUROC) of 0.381. Moreover, it detected stage 2-4 fibrosis with an AUROC of 0.400, stage 3-4 fibrosis with an AUROC of 0.687, and stage 4 fibrosis with an AUROC of 0.984. <b>Conclusion:</b> The VCTE has high clinical validity in diagnosing the advanced stages of fibrosis (stages 3, 4) and can be a suitable alternative to the invasive method of liver biopsy with high reliability.</p>","PeriodicalId":18517,"journal":{"name":"Middle East Journal of Digestive Diseases","volume":"15 1","pages":"26-31"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/37/91/mejdd-15-26.PMC10404076.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10324897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastrointestinal Stromal Tumors: Recurrence and Survival Analysis of 49 Patients. 胃肠道间质瘤49例复发及生存分析
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.34172/mejdd.2023.315
Nuray Colapkulu-Akgul, Humeyra Gunel, Damla Beyazadam, Mehmet S Ozsoy, Orhan Alimoglu

Background: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor originating from the gastrointestinal tract and have a broad spectrum of clinicopathological features affecting disease management regarding the treatment modalities. Methods: A retrospective study of 49 patients who underwent surgery for gastrointestinal tumors between 2008 and 2016 was conducted. Clinical, pathological, and immunohistochemical features of patients with and without recurrence were statistically analyzed. Results: Twenty-nine (59.1%) patients had gastric; 16 (32.6%) had small intestinal; 3 (6.1%) had mesenteric; and 1 (2.2%) had rectal GISTs. Microscopic tumor necrosis and tumor ulceration were also significant for disease recurrence (P = 0.005, P = 0.049). High-risk patients according to Miettinen's risk classification were more likely to develop a recurrence (P < 0.001). Additionally, high-grade tumors were also a risk factor for recurrence (P < 0.001). Ki-67 levels were available in 40 patients and the mean Ki-67 level was 16.8 in patients with recurrence, which was a significant risk factor in regression analysis (HR: 1.24, 95%, CI: 1.08-1-43). Five-year disease-free survival rates of non-gastric and gastric GISTs were 62.3% and 90%, respectively (P = 0.044). Conclusion: Larger tumors and higher mitotic rates are more likely to develop recurrence. High Ki-67 levels were also associated with recurrence.

背景:胃肠道间质瘤(gist)是最常见的起源于胃肠道的间质肿瘤,具有广泛的临床病理特征,影响疾病管理和治疗方式。方法:回顾性分析2008 - 2016年间49例胃肠肿瘤手术患者。统计分析复发和不复发患者的临床、病理和免疫组织化学特征。结果:29例(59.1%)患者有胃;16例(32.6%)有小肠;3例(6.1%)为肠系膜;1例(2.2%)有直肠胃肠道间质瘤。镜下肿瘤坏死和肿瘤溃疡对疾病复发也有显著意义(P = 0.005, P = 0.049)。根据Miettinen风险分类,高危患者更容易复发(P P P = 0.044)。结论:肿瘤越大,有丝分裂率越高,复发的可能性越大。高Ki-67水平也与复发有关。
{"title":"Gastrointestinal Stromal Tumors: Recurrence and Survival Analysis of 49 Patients.","authors":"Nuray Colapkulu-Akgul,&nbsp;Humeyra Gunel,&nbsp;Damla Beyazadam,&nbsp;Mehmet S Ozsoy,&nbsp;Orhan Alimoglu","doi":"10.34172/mejdd.2023.315","DOIUrl":"https://doi.org/10.34172/mejdd.2023.315","url":null,"abstract":"<p><p><b>Background:</b> Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor originating from the gastrointestinal tract and have a broad spectrum of clinicopathological features affecting disease management regarding the treatment modalities. <b>Methods:</b> A retrospective study of 49 patients who underwent surgery for gastrointestinal tumors between 2008 and 2016 was conducted. Clinical, pathological, and immunohistochemical features of patients with and without recurrence were statistically analyzed. <b>Results:</b> Twenty-nine (59.1%) patients had gastric; 16 (32.6%) had small intestinal; 3 (6.1%) had mesenteric; and 1 (2.2%) had rectal GISTs. Microscopic tumor necrosis and tumor ulceration were also significant for disease recurrence (<i>P</i> = 0.005, <i>P</i> = 0.049). High-risk patients according to Miettinen's risk classification were more likely to develop a recurrence (<i>P</i> < 0.001). Additionally, high-grade tumors were also a risk factor for recurrence (<i>P</i> < 0.001). Ki-67 levels were available in 40 patients and the mean Ki-67 level was 16.8 in patients with recurrence, which was a significant risk factor in regression analysis (HR: 1.24, 95%, CI: 1.08-1-43). Five-year disease-free survival rates of non-gastric and gastric GISTs were 62.3% and 90%, respectively (<i>P</i> = 0.044). <b>Conclusion:</b> Larger tumors and higher mitotic rates are more likely to develop recurrence. High Ki-67 levels were also associated with recurrence.</p>","PeriodicalId":18517,"journal":{"name":"Middle East Journal of Digestive Diseases","volume":"15 1","pages":"19-25"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5a/c6/mejdd-15-19.PMC10404080.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10309256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Presentation of Inlet Patch with Polypoid Kissing Pattern: Case Report. 水螅样吻型进气道贴片的新表现:附一例报告。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.34172/mejdd.2023.324
Kamyar Nikbakhsh, Ahmadreza Mojaddad, Avad Shokri Shirvani, Mohammad Ranaee

In the worldwide medical literature, only one case of inlet patch shows a kissing pattern on endoscopy. This article describes a 69-year-old female patient who came to the gastroenterology clinic, Rohani hospital, Babol University of Medical Sciences (Iran) for an examination for indigestion. Endoscopy showed two polyps in the background of a maroon patch just below the upper esophageal sphincter, oppositely positioned in view of the kissing pattern, and extending into muscular mucosa and regional lymph nodes. There was no A polyp biopsy was performed and, on histological evaluation, there was heterotopic cardiac gastric mucosa. Since heterotopic gastric mucosa can be found anywhere in the gastrointestinal tract, careful examination of the proximal esophagus increases the likelihood of detecting an inlet patch.

在世界范围内的医学文献中,只有一例进气道贴片在内窥镜上显示接吻模式。这篇文章描述了一位69岁的女性患者,她来到伊朗巴博勒医科大学鲁哈尼医院的胃肠病学诊所进行消化不良检查。内窥镜检查显示,在食管上括约肌下方的一个栗色斑块的背景处有两个息肉,与接吻模式相反,并延伸到肌肉粘膜和区域淋巴结。未行息肉活检,组织学检查发现心胃粘膜异位。由于异位胃粘膜可以在胃肠道的任何地方发现,仔细检查食管近端可以增加发现入口贴片的可能性。
{"title":"New Presentation of Inlet Patch with Polypoid Kissing Pattern: Case Report.","authors":"Kamyar Nikbakhsh,&nbsp;Ahmadreza Mojaddad,&nbsp;Avad Shokri Shirvani,&nbsp;Mohammad Ranaee","doi":"10.34172/mejdd.2023.324","DOIUrl":"https://doi.org/10.34172/mejdd.2023.324","url":null,"abstract":"<p><p>In the worldwide medical literature, only one case of inlet patch shows a kissing pattern on endoscopy. This article describes a 69-year-old female patient who came to the gastroenterology clinic, Rohani hospital, Babol University of Medical Sciences (Iran) for an examination for indigestion. Endoscopy showed two polyps in the background of a maroon patch just below the upper esophageal sphincter, oppositely positioned in view of the kissing pattern, and extending into muscular mucosa and regional lymph nodes. There was no A polyp biopsy was performed and, on histological evaluation, there was heterotopic cardiac gastric mucosa. Since heterotopic gastric mucosa can be found anywhere in the gastrointestinal tract, careful examination of the proximal esophagus increases the likelihood of detecting an inlet patch.</p>","PeriodicalId":18517,"journal":{"name":"Middle East Journal of Digestive Diseases","volume":"15 1","pages":"66-67"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/17/a5/mejdd-15-66.PMC10404079.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10324900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case of Cytomegalovirus Colitis with Subsequent Non-tubercular Mycobacteria Immune Reconstitution Inflammatory Syndrome. 巨细胞病毒结肠炎继发非结核性分枝杆菌免疫重建炎性综合征1例。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.34172/mejdd.2023.323
Syed Asif Hashmi, Sumit Arora, Inam Danish Khan, Jeenu Varghese, Rahul Pandey

Cytomegalovirus (CMV) colitis occurs commonly in immunocompromised patients with high mortality. CMV infection has also been reported in immunocompetent individuals and it has a varied clinical presentation. When HIV-infected patients are started on antiretroviral therapy (ART) there is a reconstitution of the immune system which results in the paradoxical worsening of existing conditions or development of new disease conditions known as immune reconstitution inflammatory syndrome (IRIS). In the setting of IRIS one of the most common infections to occur is non-tubercular mycobacteria (NTM). The infection generally develops when the CD4 count is < 50 cells/µL. Here we present a rare case of CMV colitis followed by NTM infection in the setting of IRIS, its management, and treatment outcomes.

巨细胞病毒(CMV)结肠炎常见于免疫功能低下患者,死亡率高。巨细胞病毒感染在免疫正常的个体中也有报道,它有不同的临床表现。当感染艾滋病毒的患者开始接受抗逆转录病毒治疗(ART)时,免疫系统会进行重建,这导致现有状况的矛盾恶化或出现新的疾病状况,称为免疫重建炎症综合征(IRIS)。在IRIS的情况下,最常见的感染之一是非结核分枝杆菌(NTM)。感染通常发生在CD4计数
{"title":"A Rare Case of Cytomegalovirus Colitis with Subsequent Non-tubercular Mycobacteria Immune Reconstitution Inflammatory Syndrome.","authors":"Syed Asif Hashmi,&nbsp;Sumit Arora,&nbsp;Inam Danish Khan,&nbsp;Jeenu Varghese,&nbsp;Rahul Pandey","doi":"10.34172/mejdd.2023.323","DOIUrl":"https://doi.org/10.34172/mejdd.2023.323","url":null,"abstract":"<p><p>Cytomegalovirus (CMV) colitis occurs commonly in immunocompromised patients with high mortality. CMV infection has also been reported in immunocompetent individuals and it has a varied clinical presentation. When HIV-infected patients are started on antiretroviral therapy (ART) there is a reconstitution of the immune system which results in the paradoxical worsening of existing conditions or development of new disease conditions known as immune reconstitution inflammatory syndrome (IRIS). In the setting of IRIS one of the most common infections to occur is non-tubercular mycobacteria (NTM). The infection generally develops when the CD4 count is < 50 cells/µL. Here we present a rare case of CMV colitis followed by NTM infection in the setting of IRIS, its management, and treatment outcomes.</p>","PeriodicalId":18517,"journal":{"name":"Middle East Journal of Digestive Diseases","volume":"15 1","pages":"63-65"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9a/b4/mejdd-15-63.PMC10404077.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10324898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Levofloxacin+Tetracycline Quadruple Regimen for Eradication of Helicobacter pylori: A Multicenter Multinational Randomized Controlled Trial. 左氧氟沙星+四环素四联疗法根除幽门螺杆菌:一项多中心多国随机对照试验。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.34172/mejdd.2023.314
Pezhman Alavinejad, Morteza Nayebi, Abazar Parsi, Eman Abdelsameea, Mohammed Hussien Ahmed, Ahmad Hormati, Dao Viet Hang, Mehdi Pezeshgi Modarres, Bahman Cheraghian, Siamak Baghaee, Tahmine Farbod Ara, Quang Trung Tran, Nitin Shanker Behl, Seyed Jalal Hashemi, Mohammed Alboraie, Saif Salman, Le Nha, Árpád V Patai, Eskandar Hajiani, Ali Akbar Abravesh

Background: The ideal combination regimen for Helicobacter pylori (HP) eradication has not yet been determined and the success rate of HP eradication has been extensively reduced worldwide due to increasing antibiotic resistance. So this multinational multi-center randomized controlled trial was designed to evaluate the efficacy of tetracycline +levofloxacin for HP eradication. Methods: During a 6-month period, all of the cases with HP infection in eight referral tertiary centers of three countries were included and randomly allocated to receive either tetracycline + levofloxacin or clarithromycin plus amoxicillin quadruple regimen for two weeks. For all of the participants, pantoprazole was continued for 4 more weeks and after one to two weeks of off-therapy, they underwent urea breath test C13 to prove eradication. Results: Overall 788 patients were included (358 male (45.4%), average age 44.2 years). They were diagnosed as having non-ulcer dyspepsia (516 cases, 65.5%), peptic ulcer disease (PUD) (234 cases, 29.69%), and intestinal metaplasia (38 cases, 4.8%). Racially 63.1% were Caucasian, 14.5% Arab, 15.6% African, and 6.1% Asian. The participants were randomly allocated to groups A and B to receive either tetracycline + levofloxacin or clarithromycin. Among groups A and B in intention to treat (ITT) and per protocol (PP) analysis, 75.2% & 82.1% (285 cases) and 67.5% & 70.1% (276 cases) of participants achieved eradication, respectively (P = 0.0001). The complete compliance rate in groups A and B were 84.4% and 83.6%, respectively. During the study, 33.5% of the participants in group A (127 cases) reported side effects while the complication rate among group B was 27.9% (114 cases, P = 0.041). The most common complaints among groups A and B were nausea and vomiting (12.6% & 9.3%) and abdominal pain (4.48% & 2.68%), respectively. The rate of severe complications that caused discontinuation of medication in groups A and B were 2.1% and 1.46%, respectively (P = 679). In subgroup analysis, the eradication rates of tetracycline+levofloxacin among patients with non-ulcer dyspepsia, PUD, and intestinal metaplasia were 79.4%, 88.1%, and 73.9%, respectively. These figures in group B (clarithromycin base) were 71.3%, 67.6%, and 61.5% respectively (P = 0.0001, 0.0001, and 0.043). Conclusion: Overall, the combination of tetracycline+levofloxacin is more efficient for HP eradication in comparison with clarithromycin+amoxicillin despite more complication rate. In areas with a high rate of resistance to clarithromycin, this therapeutic regimen could be an ideal choice for HP eradication, especially among those who were diagnosed with PUD.

背景:幽门螺杆菌(HP)根除的理想联合方案尚未确定,由于抗生素耐药性的增加,HP根除的成功率在世界范围内广泛降低。因此,本研究旨在评价四环素+左氧氟沙星根除HP的疗效。方法:选取3个国家8个转诊三级中心的HP感染病例,随机分为四环素+左氧氟沙星或克拉霉素+阿莫西林四联治疗,为期2周。对于所有的参与者,泮托拉唑继续治疗4周,停药一到两周后,他们进行尿素呼吸试验C13以证明根除。结果:共纳入788例患者,其中男性358例(45.4%),平均年龄44.2岁。诊断为非溃疡性消化不良(516例,65.5%)、消化性溃疡(PUD)(234例,29.69%)、肠化生(38例,4.8%)。从种族上看,白种人占63.1%,阿拉伯人占14.5%,非洲人占15.6%,亚洲人占6.1%。参与者被随机分为A组和B组,分别接受四环素+左氧氟沙星或克拉霉素治疗。在意向治疗组(ITT)和方案分析组(PP)中,分别有75.2%和82.1%(285例)和67.5%和70.1%(276例)的参与者实现了根除(P = 0.0001)。A组和B组完全依从率分别为84.4%和83.6%。研究过程中,A组不良反应发生率为33.5%(127例),B组并发症发生率为27.9%(114例,P = 0.041)。A组和B组最常见的主诉分别为恶心呕吐(12.6%和9.3%)和腹痛(4.48%和2.68%)。严重并发症导致停药的发生率A组为2.1%,B组为1.46% (P = 679)。在亚组分析中,非溃疡性消化不良、PUD和肠化生患者的四环素+左氧氟沙星根除率分别为79.4%、88.1%和73.9%。B组(克拉霉素碱组)分别为71.3%、67.6%和61.5% (P = 0.0001、0.0001和0.043)。结论:总体而言,与克拉霉素+阿莫西林相比,四环素+左氧氟沙星联合治疗HP根除效果更好,但并发症发生率更高。在克拉霉素耐药率高的地区,这种治疗方案可能是根除HP的理想选择,特别是对于那些被诊断为PUD的人。
{"title":"Levofloxacin+Tetracycline Quadruple Regimen for Eradication of <i>Helicobacter pylori</i>: A Multicenter Multinational Randomized Controlled Trial.","authors":"Pezhman Alavinejad,&nbsp;Morteza Nayebi,&nbsp;Abazar Parsi,&nbsp;Eman Abdelsameea,&nbsp;Mohammed Hussien Ahmed,&nbsp;Ahmad Hormati,&nbsp;Dao Viet Hang,&nbsp;Mehdi Pezeshgi Modarres,&nbsp;Bahman Cheraghian,&nbsp;Siamak Baghaee,&nbsp;Tahmine Farbod Ara,&nbsp;Quang Trung Tran,&nbsp;Nitin Shanker Behl,&nbsp;Seyed Jalal Hashemi,&nbsp;Mohammed Alboraie,&nbsp;Saif Salman,&nbsp;Le Nha,&nbsp;Árpád V Patai,&nbsp;Eskandar Hajiani,&nbsp;Ali Akbar Abravesh","doi":"10.34172/mejdd.2023.314","DOIUrl":"https://doi.org/10.34172/mejdd.2023.314","url":null,"abstract":"<p><p><b>Background:</b> The ideal combination regimen for <i>Helicobacter pylori</i> (HP) eradication has not yet been determined and the success rate of HP eradication has been extensively reduced worldwide due to increasing antibiotic resistance. So this multinational multi-center randomized controlled trial was designed to evaluate the efficacy of tetracycline +levofloxacin for HP eradication. <b>Methods:</b> During a 6-month period, all of the cases with HP infection in eight referral tertiary centers of three countries were included and randomly allocated to receive either tetracycline + levofloxacin or clarithromycin plus amoxicillin quadruple regimen for two weeks. For all of the participants, pantoprazole was continued for 4 more weeks and after one to two weeks of off-therapy, they underwent urea breath test C13 to prove eradication. <b>Results:</b> Overall 788 patients were included (358 male (45.4%), average age 44.2 years). They were diagnosed as having non-ulcer dyspepsia (516 cases, 65.5%), peptic ulcer disease (PUD) (234 cases, 29.69%), and intestinal metaplasia (38 cases, 4.8%). Racially 63.1% were Caucasian, 14.5% Arab, 15.6% African, and 6.1% Asian. The participants were randomly allocated to groups A and B to receive either tetracycline + levofloxacin or clarithromycin. Among groups A and B in intention to treat (ITT) and per protocol (PP) analysis, 75.2% & 82.1% (285 cases) and 67.5% & 70.1% (276 cases) of participants achieved eradication, respectively (<i>P</i> = 0.0001). The complete compliance rate in groups A and B were 84.4% and 83.6%, respectively. During the study, 33.5% of the participants in group A (127 cases) reported side effects while the complication rate among group B was 27.9% (114 cases, <i>P</i> = 0.041). The most common complaints among groups A and B were nausea and vomiting (12.6% & 9.3%) and abdominal pain (4.48% & 2.68%), respectively. The rate of severe complications that caused discontinuation of medication in groups A and B were 2.1% and 1.46%, respectively (<i>P</i> = 679). In subgroup analysis, the eradication rates of tetracycline+levofloxacin among patients with non-ulcer dyspepsia, PUD, and intestinal metaplasia were 79.4%, 88.1%, and 73.9%, respectively. These figures in group B (clarithromycin base) were 71.3%, 67.6%, and 61.5% respectively (<i>P</i> = 0.0001, 0.0001, and 0.043). <b>Conclusion:</b> Overall, the combination of tetracycline+levofloxacin is more efficient for HP eradication in comparison with clarithromycin+amoxicillin despite more complication rate. In areas with a high rate of resistance to clarithromycin, this therapeutic regimen could be an ideal choice for HP eradication, especially among those who were diagnosed with PUD.</p>","PeriodicalId":18517,"journal":{"name":"Middle East Journal of Digestive Diseases","volume":"15 1","pages":"12-18"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ac/29/mejdd-15-12.PMC10404071.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10324903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Acute Pancreatitis Associated with Weil's Disease. 与韦尔氏病相关的严重急性胰腺炎。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.34172/mejdd.2023.320
Meriem Guechi, Wahiba Guenifi, Abdelkader Gasmi, Amel Ouyahia, Mounira Rais, Houda Boukhrissa, Salah Mechakra, Habiba Hemamid, Abdelmalek Hakimi, Abdelmadjid Lacheheb

Leptospirosis is an emerging zoonosis of worldwide importance. Its distribution is closely linked to hydrometric conditions. It is characterized by a wide clinical range, from the subclinical form, or one with few symptoms; which resolves spontaneously, to the multi-visceral form, known as icterrohemorrhagic disease or Weil's disease, with a lethal risk. All organs can be affected but with variable frequency. Pancreatic involvement is not well documented. We describe a 45-year-old man with Weil's disease associated with acute necrotizing pancreatitis. The evolution was favorable but required a three-week stay in the intensive care unit.

钩端螺旋体病是一种新兴的具有世界重要性的人畜共患病。它的分布与水文条件密切相关。它的特点是临床范围很广,从亚临床形式到几乎没有症状;这种疾病会自发地发展成多内脏形式,即众所周知的出血性疾病或韦尔氏病,具有致命的风险。所有器官都可能受到影响,但频率不同。胰腺受累情况没有很好的文献记载。我们描述了一个45岁的男性韦尔病与急性坏死性胰腺炎。病情的发展是有利的,但需要在重症监护室呆上三周。
{"title":"Severe Acute Pancreatitis Associated with Weil's Disease.","authors":"Meriem Guechi,&nbsp;Wahiba Guenifi,&nbsp;Abdelkader Gasmi,&nbsp;Amel Ouyahia,&nbsp;Mounira Rais,&nbsp;Houda Boukhrissa,&nbsp;Salah Mechakra,&nbsp;Habiba Hemamid,&nbsp;Abdelmalek Hakimi,&nbsp;Abdelmadjid Lacheheb","doi":"10.34172/mejdd.2023.320","DOIUrl":"https://doi.org/10.34172/mejdd.2023.320","url":null,"abstract":"<p><p>Leptospirosis is an emerging zoonosis of worldwide importance. Its distribution is closely linked to hydrometric conditions. It is characterized by a wide clinical range, from the subclinical form, or one with few symptoms; which resolves spontaneously, to the multi-visceral form, known as icterrohemorrhagic disease or Weil's disease, with a lethal risk. All organs can be affected but with variable frequency. Pancreatic involvement is not well documented. We describe a 45-year-old man with Weil's disease associated with acute necrotizing pancreatitis. The evolution was favorable but required a three-week stay in the intensive care unit.</p>","PeriodicalId":18517,"journal":{"name":"Middle East Journal of Digestive Diseases","volume":"15 1","pages":"53-56"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/98/7c/mejdd-15-53.PMC10404078.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9953331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Biofeedback Treatment Can Improve Clinical Condition and Quality of Life in Patients with Pelvic Floor Dyssynergy with Irritable Bowel Syndrome: A Prospective Cohort Study. 一项前瞻性队列研究:生物反馈治疗可改善盆底协同失调伴肠易激综合征患者的临床状况和生活质量。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.34172/mejdd.2023.319
Foroogh Alborzi Avanaki, Sara Rafiee, Hesam Aldin Varpaei, Mohammad Taher, Najmeh Aletaha, Farshad Allameh

Background: Chronic constipation is a common health concern. Defecatory disorders are considered one of the mechanisms of chronic idiopathic constipation. This study aimed to evaluate the effect of concurrent irritable bowel syndrome (IBS) on the success rate and response to biofeedback therapy in patients with chronic constipation and pelvic floor dyssynergia (PFD). Methods: This prospective cohort study was performed at the Imam Khomeini Hospital Complex in Tehran from October 2020 to July 2021. Patients aged 18-70 years with chronic constipation and PFD confirmed by clinical examination, anorectal manometry, balloon expulsion test, and/or defecography were included. All patients failed to respond to treatment with lifestyle modifications and laxative use. The diagnosis of IBS was based on the ROME IV criteria. Biofeedback was educated and recommended to all patients. We used three different metrics to assess the patient's response to biofeedback: 1) constipation score (questionnaire), 2) lifestyle score (questionnaire), and 3) manometry findings (gastroenterologist report). Results: Forty patients were included in the final analysis, of which 7 men (17.5%) and 21 (52.2%) had IBS. The mean age of the study population was 37.7 ± 11.4. The average resting pressure decreased in response to treatment; however, this decrease was statistically significant only in non-IBS patients (P = 0.007). Patients with and without IBS showed an increase in the percentage of anal sphincter relaxation in response to treatment, but this difference was not statistically significant. Although the first sensation decreased in both groups, this decrease was not statistically significant. Overall, the clinical response was the same across IBS and non-IBS patients, but constipation and lifestyle scores decreased significantly in both groups of patients with and without IBS (P < 0.001). Conclusion: Biofeedback treatment appears to improve the clinical condition and quality of life of patients with PFD. Considering that a better effect of biofeedback in correcting some manometric parameters has been seen in patients with IBS, it seems that paying attention to the association between these two diseases can be helpful in deciding on treatment.

背景:慢性便秘是一种常见的健康问题。排便障碍被认为是慢性特发性便秘的机制之一。本研究旨在评估并发性肠易激综合征(IBS)对慢性便秘和盆底协同功能障碍(PFD)患者生物反馈治疗成功率和反应的影响。方法:这项前瞻性队列研究于2020年10月至2021年7月在德黑兰伊玛目霍梅尼医院综合医院进行。患者年龄18-70岁,经临床检查、肛肠测压、球囊排出试验和/或排便造影证实为慢性便秘和PFD。所有患者对改变生活方式和使用泻药治疗均无效。IBS的诊断基于ROME IV标准。对所有患者进行生物反馈教育和推荐。我们使用三种不同的指标来评估患者对生物反馈的反应:1)便秘评分(问卷),2)生活方式评分(问卷),3)测压结果(胃肠病学报告)。结果:40例患者纳入最终分析,其中男性7例(17.5%),21例(52.2%)为IBS。研究人群的平均年龄为37.7±11.4岁。平均静息压随治疗而降低;然而,这种下降仅在非肠易激综合征患者中有统计学意义(P = 0.007)。有IBS和没有IBS的患者在治疗后肛门括约肌松弛的百分比有所增加,但这种差异没有统计学意义。尽管两组的第一感觉都有所下降,但这种下降在统计学上并不显著。总体而言,IBS和非IBS患者的临床反应相同,但两组IBS患者和非IBS患者的便秘和生活方式评分均显著下降(P结论:生物反馈治疗似乎改善了PFD患者的临床状况和生活质量。考虑到生物反馈在IBS患者中纠正某些血压参数的效果较好,似乎关注这两种疾病之间的关联有助于决定治疗方案。
{"title":"Biofeedback Treatment Can Improve Clinical Condition and Quality of Life in Patients with Pelvic Floor Dyssynergy with Irritable Bowel Syndrome: A Prospective Cohort Study.","authors":"Foroogh Alborzi Avanaki,&nbsp;Sara Rafiee,&nbsp;Hesam Aldin Varpaei,&nbsp;Mohammad Taher,&nbsp;Najmeh Aletaha,&nbsp;Farshad Allameh","doi":"10.34172/mejdd.2023.319","DOIUrl":"https://doi.org/10.34172/mejdd.2023.319","url":null,"abstract":"<p><p><b>Background:</b> Chronic constipation is a common health concern. Defecatory disorders are considered one of the mechanisms of chronic idiopathic constipation. This study aimed to evaluate the effect of concurrent irritable bowel syndrome (IBS) on the success rate and response to biofeedback therapy in patients with chronic constipation and pelvic floor dyssynergia (PFD). <b>Methods:</b> This prospective cohort study was performed at the Imam Khomeini Hospital Complex in Tehran from October 2020 to July 2021. Patients aged 18-70 years with chronic constipation and PFD confirmed by clinical examination, anorectal manometry, balloon expulsion test, and/or defecography were included. All patients failed to respond to treatment with lifestyle modifications and laxative use. The diagnosis of IBS was based on the ROME IV criteria. Biofeedback was educated and recommended to all patients. We used three different metrics to assess the patient's response to biofeedback: 1) constipation score (questionnaire), 2) lifestyle score (questionnaire), and 3) manometry findings (gastroenterologist report). <b>Results:</b> Forty patients were included in the final analysis, of which 7 men (17.5%) and 21 (52.2%) had IBS. The mean age of the study population was 37.7 ± 11.4. The average resting pressure decreased in response to treatment; however, this decrease was statistically significant only in non-IBS patients (<i>P</i> = 0.007). Patients with and without IBS showed an increase in the percentage of anal sphincter relaxation in response to treatment, but this difference was not statistically significant. Although the first sensation decreased in both groups, this decrease was not statistically significant. Overall, the clinical response was the same across IBS and non-IBS patients, but constipation and lifestyle scores decreased significantly in both groups of patients with and without IBS (<i>P</i> < 0.001). <b>Conclusion:</b> Biofeedback treatment appears to improve the clinical condition and quality of life of patients with PFD. Considering that a better effect of biofeedback in correcting some manometric parameters has been seen in patients with IBS, it seems that paying attention to the association between these two diseases can be helpful in deciding on treatment.</p>","PeriodicalId":18517,"journal":{"name":"Middle East Journal of Digestive Diseases","volume":"15 1","pages":"45-52"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3d/87/mejdd-15-45.PMC10404073.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10309261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Multimedia CD Education on the Quality of Colon Preparation; A Single-Blind Randomized Study. 多媒体光盘教育对结肠准备质量的影响一项单盲随机研究。
Q3 Medicine Pub Date : 2022-10-01 DOI: 10.34172/mejdd.2022.304
Fardad Ejtehadi, Ali Reza Safarpour, Rasoul Nemati, Ladan Aminlari, Ehsan Zare, Gholam Reza Sivandzadeh, Ramin Niknam

Background: Routine bowel preparation instructions are usually given to patients in the form of oral explanations with written instructions. The purpose of this study was to evaluate the effectiveness of multimedia training in the form of video CDs on the quality of colon preparation and other related indicators. Methods: 201 outpatients in three referral academic colonoscopy centers were randomly assigned to two groups. The first group (n=100) received supplementary video CD education besides the routine instructions (VCD group). The second group (n=101) received only routine instruction, which included oral and printed instructions (non-VCD group). Results: Complete use of colon cleansing medication was statistically and significantly better in the VCD group (P=0.038). Duration of colonoscopy was shorter in the VCD group (P=0.001), demand for conscious sedation was lesser in the VCD group (P=0.049), and the quality of colon preparation was better in the VCD group (P<0.00). There was no statistically significant difference in pain sensation (P=0.1), cecal intubation rate (P=0.3), and technical difficulty of the colonoscopy (P=0.1) in both groups. Conclusion: Supplementary education in the form of multimedia CD increases the patients' compliance to cleansing mediation consumption, improves the quality of bowel preparation, and decreases the duration of colonoscopy with lesser demands for conscious sedation.

背景:常规肠准备指导通常以口头解释和书面说明的形式给予患者。本研究的目的是评价视频cd形式的多媒体培训对结肠准备质量及其他相关指标的有效性。方法:将3家转诊学术结肠镜中心201例门诊患者随机分为两组。第一组(n=100)在常规教学的基础上进行辅助视频CD教育(VCD组)。第二组(n=101)只接受常规教学,包括口头和印刷教学(非vcd组)。结果:VCD组结肠清洁药物的完全使用有统计学意义(P=0.038)。VCD组结肠镜检查时间较短(P=0.001), VCD组清醒镇静需求较少(P=0.049),两组结肠镜准备质量(PP=0.1)、盲肠插管率(P=0.3)、结肠镜检查技术难度(P=0.1)均较VCD组好。结论:多媒体CD形式的辅助教育提高了患者对清洁介质消耗的依从性,提高了肠准备质量,缩短了结肠镜检查时间,减少了对清醒镇静的需求。
{"title":"Impact of Multimedia CD Education on the Quality of Colon Preparation; A Single-Blind Randomized Study.","authors":"Fardad Ejtehadi,&nbsp;Ali Reza Safarpour,&nbsp;Rasoul Nemati,&nbsp;Ladan Aminlari,&nbsp;Ehsan Zare,&nbsp;Gholam Reza Sivandzadeh,&nbsp;Ramin Niknam","doi":"10.34172/mejdd.2022.304","DOIUrl":"https://doi.org/10.34172/mejdd.2022.304","url":null,"abstract":"<p><p><b>Background</b>: Routine bowel preparation instructions are usually given to patients in the form of oral explanations with written instructions. The purpose of this study was to evaluate the effectiveness of multimedia training in the form of video CDs on the quality of colon preparation and other related indicators. <b>Methods</b>: 201 outpatients in three referral academic colonoscopy centers were randomly assigned to two groups. The first group (n=100) received supplementary video CD education besides the routine instructions (VCD group). The second group (n=101) received only routine instruction, which included oral and printed instructions (non-VCD group). <b>Results</b>: Complete use of colon cleansing medication was statistically and significantly better in the VCD group (<i>P</i>=0.038). Duration of colonoscopy was shorter in the VCD group (<i>P</i>=0.001), demand for conscious sedation was lesser in the VCD group (<i>P</i>=0.049), and the quality of colon preparation was better in the VCD group (<i>P</i><0.00). There was no statistically significant difference in pain sensation (<i>P</i>=0.1), cecal intubation rate (<i>P</i>=0.3), and technical difficulty of the colonoscopy (<i>P</i>=0.1) in both groups. <b>Conclusion</b>: Supplementary education in the form of multimedia CD increases the patients' compliance to cleansing mediation consumption, improves the quality of bowel preparation, and decreases the duration of colonoscopy with lesser demands for conscious sedation.</p>","PeriodicalId":18517,"journal":{"name":"Middle East Journal of Digestive Diseases","volume":"14 4","pages":"431-436"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/58/e6/mejdd-14-431.PMC10404098.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9950601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overt Bleeding from Small Bowel Ulcers due to Microscopic Polyangiitis. 显微镜下多血管炎引起的小肠溃疡明显出血。
Q3 Medicine Pub Date : 2022-10-01 DOI: 10.34172/mejdd.2022.312
João Correia, Catarina Gomes, Ana Ponte, David João, Teresa Freitas
Middle East J Dig Dis, Vol. 14, No. 4, October 2022 © 2022 The Author(s). This work is published by Middle East Journal of Digestive Diseaes as an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/bync/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. DOI: 10.34172/mejdd.2022.312 Photoclinic
{"title":"Overt Bleeding from Small Bowel Ulcers due to Microscopic Polyangiitis.","authors":"João Correia,&nbsp;Catarina Gomes,&nbsp;Ana Ponte,&nbsp;David João,&nbsp;Teresa Freitas","doi":"10.34172/mejdd.2022.312","DOIUrl":"https://doi.org/10.34172/mejdd.2022.312","url":null,"abstract":"Middle East J Dig Dis, Vol. 14, No. 4, October 2022 © 2022 The Author(s). This work is published by Middle East Journal of Digestive Diseaes as an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/bync/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. DOI: 10.34172/mejdd.2022.312 Photoclinic","PeriodicalId":18517,"journal":{"name":"Middle East Journal of Digestive Diseases","volume":"14 4","pages":"488-490"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d1/8a/mejdd-14-488.PMC10404103.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10007356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Middle East Journal of Digestive Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1